Oncology

Oncology clinical trials face new challenges with the continued advent of novel therapeutic areas in targeted cancer therapies and personalised immunotherapy. This increases the pressure to deliver precise tumor phenotyping, staging and early outcome predictors in trials. These are key areas where medical imaging is proving to be a critical component for the timely delivery of endpoints in oncology trials.

ICON has a highly experienced Oncology imaging service that is underpinned by a robust team of specialists that have more than 250 Oncology imaging trials under their wing, contributing to over 21 approvals by the FDA.

We work with thousands of sites across the globe to provide support, image quality assessments, reconciliation, and post processing.

Our team of highly trained specialists include key opinion leaders in radiology and clinical oncology, medical imaging experts, oncology study coordinators, biomedical engineers, statisticians, and allied support personnel.

Our specialists have vast experience with a wide variety of cancers, their treatments, and their image assessment criteria. They have mastered imaging technologies including CT, MRI, PET-CT, Nuclear Medicine, and Ultrasound which ensures your requirements are met for the successful completion of your trial.

• Indications include:  Breast, Colorectal, Gastric, Glioblastoma, Glioma, Head and Neck, Lung, Lymphoma, Melanoma, Ovarian Prostate, Renal Cell

• Criteria include: RECIST, mRECIST, Choi, RANO, Cheson, Lugano Classification, Halleck, iRECIST, RECIL, iRANO/bmRANO/pedRANO, PCWG, PCWG3

Delivering benefits to your oncology study:

 

- Access to close to 700 highly trained radiologists

Wiith experience in body imaging, PET imaging and Nuclear medicine.

- Integrated clinical and medical imaging service teams

That have direct lines of communication, facilitating and streamlining project management. We prioritise study timelines across clinical and imaging services during start-up to minimise time to first patient in (FPI), and after last patient out (LPO) to reduce time to database lock.

- A range of support resources

Including in-house scientific experts, data management specialists, medical writing and translation services.

- High quality training support

Provided to the CTM/CRA team which assists with overall knowledge, timely submission of imaging, and the importance of open lines of communication with key site contacts.

- Greater accountability and collaboration

Across service teams for early identification and mitigation of study risks, lower query rates, and prompt implementation of any required corrective and preventative actions.